At the same time, the genotype can condition the GC benefit: in LKB1-mutant NSCLC, dexamethasone induces CDKN1C/p57 and G1/S arrest, nominating LKB1/CPS1 as stratification markers for GR-directed interventions. Here, CPS1 is linked to non-small cell lung carcinoma.